March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
Driving Cessation, Driving Restriction, And Driver Preference In Older Adults With Glaucoma And Macular Degeneration
Author Affiliations & Notes
  • Suzanne W. van Landingham
    Wilmer Eye Institute, Baltimore, Maryland
  • Chad Hochberg
    Wilmer Eye Institute, Baltimore, Maryland
  • Robert W. Massof
    Wilmer Eye Institute, Baltimore, Maryland
  • Emilie Chan
    Wilmer Eye Institute, Baltimore, Maryland
  • David S. Friedman
    Wilmer Eye Institute, Baltimore, Maryland
  • Pradeep Y. Ramulu
    Wilmer Eye Institute, Baltimore, Maryland
  • Footnotes
    Commercial Relationships  Suzanne W. van Landingham, None; Chad Hochberg, None; Robert W. Massof, Alcon Research Institute (F), Multiple District 22 Lions Vision Research Foundation (F), National Eye Institute (F), Readers Digest Foundation (F), Research to Prevent Blindness (F); Emilie Chan, None; David S. Friedman, None; Pradeep Y. Ramulu, American Geriatrics Society (F), Research to Prevent Blindness (F)
  • Footnotes
    Support  D. W. Jahnigen Mem. Award, NIH Grant EY018595, Research to Prevent Blindness R and H Shaub Special Scholar Award, Intramural Research Program of the NIH (NIA), & Doris Duke Clinical Research Fellowshi
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 4354. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Suzanne W. van Landingham, Chad Hochberg, Robert W. Massof, Emilie Chan, David S. Friedman, Pradeep Y. Ramulu; Driving Cessation, Driving Restriction, And Driver Preference In Older Adults With Glaucoma And Macular Degeneration. Invest. Ophthalmol. Vis. Sci. 2012;53(14):4354.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To determine if glaucoma and/or macular degeneration (AMD) is associated with driving limitation, driving cessation, or driver preference in older adults.

Methods: : Fifty-eight control subjects with normal vision, 81 glaucoma patients with bilateral visual field (VF) loss, and 48 AMD subjects with bilateral or severe unilateral visual acuity (VA) loss reported their driving habits via questionnaires. All subjects were between the ages of 60 and 80. Main outcome measures were driving cessation, the number of driving limitations, and other driver preference (preferring another adult to drive when possible).

Results: : Driving cessation was noted in 22.5% glaucoma (p=0.01) and 28.3% AMD subjects (p=0.003) as compared to 6.9% of controls. More driving restrictions were present in glaucoma (mean=2.0, p=0.007) and AMD (mean=2.5, p<0.001) subjects than controls (mean=1.1). In multivariable models, driving cessation was more likely in glaucoma subjects as compared to controls (OR=4.0; 95% CI=1.1-14.7; P=0.03) and the odds of driving cessation doubled with each 5 decibel (dB) decrement in the better-eye VF (OR=2.0; 95% CI=1.4-2.9; p<0.001). Driving cessation was marginally more likely for AMD subjects (OR=3.6; 95% CI=0.94-14.2; p=0.06) and the odds of cessation increased with each one-line decrement in vision (OR=1.5; 95% CI=1.2-1.9; p<0.001). Glaucoma and AMD subjects were both more likely to report a greater number of driving restrictions than controls (OR=4.7; 95% CI=1.3-16.8; p=0.02 and OR=4.3; 95% CI 1.1-16.1; p=0.03), and the likelihood of reporting more restrictions increased with the severity of VF and VA loss (OR=1.6 / 5 dB decrement in the better-eye VF; 95% CI=1.1-2.4; p=0.02 and OR=2.0 / line of VA; 95% CI 1.4-3.0; p0.05 for both).

Conclusions: : Glaucoma and AMD are associated with driving cessation and restriction of driving in the elderly, and driving becomes more limited with worsening VF and VA loss. These data indicate that glaucoma and AMD may have a substantial impact on independence and mobility in aging populations.

Keywords: aging: visual performance • age-related macular degeneration • clinical (human) or epidemiologic studies: outcomes/complications 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×